News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Articles|October 2, 2017

Take the CURE Magazine Survey

Author(s)Staff

Thank you for answering the questions below.

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
multiple myeloma

KRd Improves Progression in Newly Diagnosed Patients With Myeloma

ByJax DiEugenio
December 7th 2025
Image of man.

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

ByDr. James Berenson
December 7th 2025
lymphoms

Odronextamab Plus CHOP Shows Early Efficacy in DLBCL

BySilas Inman
December 6th 2025
multiple myeloma

Elrexfio Maintains Responses in Elderly, Frail Patients With Multiple Myeloma

ByTim Cortese
December 6th 2025
leukemia

Fixed Duration Venclexta Combos Delay Progression in CLL Similarly to Imbruvica

ByGina Mauro
December 6th 2025
Advertisement
Advertisement

Trending on CURE

1

Every FDA Oncology Approval From November 2025

2

Reflecting on My Sister’s Final Days After Years of Unexpected Rebounds

3

Chemo Side Effects for Breast Cancer Led to Weeks in the Hospital

4

First Annual Blood Cancer Heroes Honors Leaders, Advocates and Survivors

5

Fixed Duration Venclexta Combos Delay Progression in CLL Similarly to Imbruvica

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.